SLXNWSilexion Therapeutics Corp同业对比
Silexion Therapeutics Corp 与Biological Products, (No Diagnostic Substances)的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Biological Products, (No Diagnostic Substances))| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLXNW本股 | $99529#11 | 0.0x#1 | 2.3x#3 | — | — | 27.9%#7 | — | -27072.7%#3 | — | — | -53.0%#5 | — |
| CRIS | $2M#4 | 0.1x#5 | 0.5x#1 | 0.3x#3 | -13.4%#7 | 82.5%#3 | -60.5%#4 | -161.5%#1 | -87.3%#1 | — | -96.2%#8 | — |
| CLDI | $2M#6 | 0.0x#4 | 0.6x#2 | 43.1x#7 | — | 10.1%#10 | -44977.8%#9 | -635.4%#2 | — | — | -96.9%#9 | — |
| SLXN | $841267#7 | 0.0x#2 | 19.1x#4 | — | — | 27.9%#7 | — | -27072.7%#3 | — | — | -99.5%#10 | — |
| TVGNW | $526132#8 | — | — | — | — | -91.4%#12 | — | — | — | — | 86.2%#2 | — |
| VIVS | $2M#5 | — | — | 17.0x#6 | -9.0%#6 | -456.4%#14 | -8768.7%#8 | — | — | — | -93.3%#7 | — |
| SCLXW | $356706#9 | — | — | 0.0x#1 | -46.5%#8 | -413.8%#13 | -1143.7%#5 | — | — | 4#1 | 382.5%#1 | — |
| ABPWW | $116152#10 | 0.0x#3 | — | 0.6x#4 | 50.0%#2 | 60.0%#4 | -4618.6%#6 | — | — | — | -19.3%#4 | — |
| ABPO | — | — | — | — | 50.0%#2 | 60.0%#4 | -4618.6%#6 | — | — | — | — | — |
| ADAPY | — | — | — | — | 195.3%#1 | 37.8%#6 | -38.6%#3 | — | — | — | — | — |
| AGMB | $234M#2 | — | — | — | — | — | — | — | — | — | — | — |
| AGTX | — | — | — | — | -100.0%#9 | 14.4%#9 | — | — | — | — | — | — |
| ALVO | $1.5B#1 | — | — | 2.5x#5 | 19.7%#4 | 112.0%#1 | 13.3%#1 | — | — | — | -3.1%#3 | — |
| ALVOW | $144M#3 | — | — | 0.2x#2 | 19.7%#4 | 112.0%#1 | 13.3%#1 | — | — | — | -60.0%#6 | — |
| APTN | — | — | — | — | — | -65.5%#11 | — | — | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-11-05。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议